Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192887 · ClinicalTrials.gov registry record
Thebaine Urine Testing
A clinical trial of Urine Specimen Collection, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07192887: Recruiting study of Urine Specimen Collection, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07192887 is a study of Urine Specimen Collection that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07192887, a study of Urine Specimen Collection, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop and validate a urine drug screen to detect thebaine.
Primary Outcome
Validate a liquid chromatography-tandem mass spectrometry method to detect thebaine in urine
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-05-07 |
| Est. Completion | 2027-03 |
What NCT07192887 shows while recruiting
NCT07192887 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Urine Specimen Collection appearing as the primary indexed condition, and to 0 interventions.
NCT07192887 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07192887 about?
NCT07192887 is a clinical study titled "Thebaine Urine Testing". To develop and validate a urine drug screen to detect thebaine.
What is the current status of trial NCT07192887?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-05-07. Estimated completion is 2027-03.
What conditions does trial NCT07192887 study?
This clinical trial studies the following conditions: Urine Specimen Collection.
Who is sponsoring clinical trial NCT07192887?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192887 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI